Background:  LMW (Low Molecular Weight) kininogen is a major extracellular cysteine proteinase inhibitor. It is split by tissue kallikrein to produce kallidin. Kallidin, in turn, is converted into bradykinin. The kallikreinkinin system is a mediator of inflammation in humans.

Description: Rabbit polyclonal to Kininogen 1

Immunogen: KLH conjugated synthetic peptide derived from Kininogen 1

Specificity:  ·Reacts with Human, Mouse and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/100-500. Predicted Mol wt: 48 kDa;

·Immunohistochemistry (Paraffin/frozen tissue section): 1/100-500;

·Immunocytochemistry: 1/100;

·Immunoprecipitation: 1/50;

·ELISA: 1/500;

·Optimal working dilutions must be determined by the end user.